Brewin Dolphin LTD Orchard Therapeutics PLC Call Options Transaction History
Brewin Dolphin LTD
- $2.08 Billion
- Q2 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ORTX
# of Institutions
4Shares Held
545KCall Options Held
0Put Options Held
0-
Strategic Wealth Advisors Group, LLC Sacramento, CA517KShares$00.01% of portfolio
-
Altium Wealth Management LLC22KShares$00.0% of portfolio
-
American Portfolios Advisors Holbrook, NY6.38KShares$00.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About Orchard Therapeutics plc
- Ticker ORTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,458,000
- Description
- Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...